Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry studyDavid J. Pinato, David García-Illescas, Josep Tabernero et al.|The Lancet Oncology|2021Cited by 136
Time-Dependent COVID-19 Mortality in Patients With CancerOnCovid study group, Ariadna Roqué, David J. Pinato et al.|JAMA Oncology|2021Cited by 72
An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitmentMarcus Jepson, Ann French, Daisy Elliott et al.|Journal of Clinical Epidemiology|2018Cited by 68
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European studyDavid J. Pinato, Yien Ning Sophia Wong, Lorenza Scotti et al.|European Journal of Cancer|2021Cited by 51
Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for CancerTimothy Kottke, Richard G. Vile, Rosa María Díaz et al.|Molecular Therapy|2008Cited by 47